spacer
home > pmps > autumn 2003 > drug delivery: an evolving concept
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drug Delivery: An Evolving Concept

The concept of drug delivery is evolving to go far beyond its original focus of finding alternative modes of administration in order to reduce drug side effects and prolong drug action over time. Pharmaceutical and biotechnology companies are now exploiting a variety of new technologies and novel approaches to drug delivery, using delivery concepts to develop high-value, differentiated products. These drug delivery applications are increasingly considered an integral part of the development process - one that not only offers strategies to expand product pipelines and extend product and patent life, but is also critical to the development of superior and, in some cases, breakthrough therapies.

The concept of drug delivery was born in the early 1970s. As originally conceived, drug delivery applications focused principally on finding alternative modes of administration - notably transdermal patch and oral sustained release formulations - in order to reduce drug side effects and prolong the action of drugs over time. Since then, however, the field of drug delivery has evolved into an array of technologies that provide new routes of administration or extended performance for both novel and established pharmaceuticals. Pharmaceutical companies have increasingly used drug delivery technologies to enhance the competitiveness of their products, addressing strategic business goals as well as goals focused on improved drug performance:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Christopher Searcy, Vice President of Corporate Development at Nektar Therapeutics

Christopher J Searcy, Pharm D, is Vice President of Corporate Development at Nektar Therapeutics (Inhale). He joined the company from GalaGen Inc, in Minnesota, where he was Vice President of Business Development. From 1985 to 1995, he held various positions at Pfizer Inc in registration and regulatory affairs, clinical research and marketing. His last position at Pfizer was Director, Licensing and Development. He holds a Master of Business Administration from the University of Pennsylvania, Wharton School, and a Pharm D from the University of Minnesota.

spacer
Christopher J Searcy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo awarded with the prestigious Cargo Airline of the Year 2019 prize by the global logistics industry

 Maintaining its upward trend, Turkish Cargo was granted with the ‘Cargo Airline of the Year 2019’ award, called as the Oscar of the global logistics industry, by the global air cargo sector readers of the Air Cargo News magazine.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement